Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

From a pharmaceutical strategy perspective, the off-label success of semaglutide and tirzepatide in T1D has significant implications for market dynamics. The growing interest in adjunctive ...

The iconic Hemi V-8 engine was controversially dropped from the Dodge and Ram lineups for the 2025 model year, abandoning the powerplant that established the Charger, Challenger, and Ram vehicles ...

On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...

When petrol-head Tim Kuniskis returned to Stellantis and his old role as Ram brand CEO in December, having retired in June, the most-asked question was whether he would bring back the Hemi V-8 ...

The Ram 1500 will reportedly be offered with 5.7- and 6.4-liter Hemi V8 engines. The TRX is rumored to return with more power than its predecessor for 2025. Power Wagon fans might soon be able to ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.